Chr. Hansen

About:

Chr. Hansen is a bioscience company that develops natural solutions for the food, nutritional, pharmaceutical, and agricultural industries.

Website: http://www.chr-hansen.com/en

Twitter/X: chr_hansen

Top Investors: Novo Holdings

Description:

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. It develops and produces cultures, enzymes, probiotics, and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements, and even animal feed. All solutions are based on strong research and development competencies coupled with significant technology investments. Chr. Hansen has more than 2,500 employees in 30 countries and main production facilities in Denmark, France, USA, and Germany. It was founded in 1874 and is listed on Nasdaq Copenhagen.

Total Funding Amount:

560M EUR

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Hørsholm, Hovedstaden, Denmark

Founded Date:

1874-01-01

Contact Email:

info(AT)chr-hansen.com

Founders:

Christian Hansen

Number of Employees:

10001+

Last Funding Date:

2012-01-11

IPO Status:

Public

© 2025 bioDAO.ai